Skip to Content

Acusphere Inc ACUS

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ACUS is trading at a 184% premium.
Price
$0.00
Fair Value
$1.89
Uncertainty
Extreme
1-Star Price
$5.53
5-Star Price
Economic Moat
Qqccz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ACUS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.03 / $0.10
Market Cap
$4.95
Volume/Avg
225 / 527

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
118
Website

Valuation

Metric
ACUS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ACUS
Quick Ratio
0.21
Current Ratio
0.29
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
ACUS
Return on Assets (Normalized)
−105.90%
Return on Equity (Normalized)
−400.58%
Return on Invested Capital (Normalized)
−169.06%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ANxthzyddgMpgw$79.4 Bil
MKKGY
Merck KGaA ADRMwhvnsxdzzCdsmyx$79.0 Bil
HLN
Haleon PLC ADRVmkwgtsfmWbdy$38.5 Bil
VTRS
Viatris IncQrwqqdpdxShqyl$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRPdjglvgftXqk$11.7 Bil
CTLT
Catalent IncVvdfcpdxYcfjy$10.0 Bil
CURLF
Curaleaf Holdings IncXvdbdlbDkdt$4.2 Bil
PRGO
Perrigo Co PLCDxqxnjyvtGynl$4.1 Bil
PBH
Prestige Consumer Healthcare IncZxhfgfbsVyhsy$3.2 Bil
GTBIF
Green Thumb Industries IncFmchfwdtzyWzchg$3.1 Bil

Sponsor Center